STING1 and neoplasm: Augmented STING in tumor cells reprograms the TME, rendering ‘cold ' tumors sensitive to checkpoint inhibitors, thus transforming ‘cold’ tumors into hot’ tumors, which enhances the efficacy of anti-tumor immunotherapy [43].